Multiple Adversarial Learning based Angiography Reconstruction for Ultra-low-dose Contrast Medium CT

Which is a real valuable screening tool for lung cancer and measure thoracic diseases, chest radiography or low-dose computed tomography?: A review on the current status of Japan and other countries

Chest radiography (CR) has been used as a screening tool for lung cancer and the use of low-dose computed tomography (LDCT) is not recommended in Japan. We need to reconsider whether CR really contributes to the early detection of lung cancer. In addition, we have not well discussed about other major thoracic disease detection by CR and LDCT compared with lung cancer despite of its high frequency. We review the usefulness of CR and LDCT as veridical screening tools for lung cancer and other thoracic diseases. In the case of lung cancer, many studies showed that LDCT has capability of early detection and improving outcomes compared with CR. Recent large randomized trial also supports former results. In the case of chronic obstructive pulmonary disease (COPD), LDCT contributes to early detection and leads to the implementation of smoking cessation treatments. In the case of pulmonary infections, LDCT can reveal tiny inflammatory changes that are not observed on CR, though many of these cases improve spontaneously. Therefore, LDCT screening for pulmonary infections may be less useful. CR screening is more suitable for the detection of pulmonary infections. In the case of cardiovascular disease (CVD), CR may be a better screening tool for detecting cardiomegaly, whereas LDCT may be a more useful tool for detecting vascular changes. Therefore, the current status of thoracic disease screening is that LDCT may be a better screening tool for detecting lung cancer, COPD, and vascular changes. CR may be a suitable screening tool for pulmonary infections and cardiomegaly.

Spectrum learning for super-resolution tomographic reconstruction

Objective. Computed Tomography (CT) has been widely used in industrial high-resolution non-destructive testing. However, it is difficult to obtain high-resolution images for large-scale objects due to their physical limitations. The objective is to develop an improved super-resolution technique that preserves small structures and details while efficiently capturing high-frequency information.Approach. The study proposes a new deep learning based method called spectrum learning (SPEAR) network for CT images super-resolution. This approach leverages both global information in the image domain and high-frequency information in the frequency domain. The SPEAR network is designed to reconstruct high-resolution images from low-resolution inputs by considering not only the main body of the images but also the small structures and other details. The symmetric property of the spectrum is exploited to reduce weight parameters in the frequency domain. Additionally, a spectrum loss is introduced to enforce the preservation of both high-frequency components and global information.Main results. The network is trained using pairs of low-resolution and high-resolution CT images, and it is fine-tuned using additional low-dose and normal-dose CT image pairs. The experimental results demonstrate that the proposed SPEAR network outperforms state-of-the-art networks in terms of image reconstruction quality. The approach successfully preserves high-frequency information and small structures, leading to better results compared to existing methods. The network's ability to generate high-resolution images from low-resolution inputs, even in cases of low-dose CT images, showcases its effectiveness in maintaining image quality.Significance. The proposed SPEAR network's ability to simultaneously capture global information and high-frequency details addresses the limitations of existing methods, resulting in more accurate and informative image reconstructions. This advancement can have substantial implications for various industries and medical diagnoses relying on accurate imaging.

Applications of deep learning to reduce the need for iodinated contrast media for CT imaging: a systematic review

PURPOSE

The usage of iodinated contrast media (ICM) can improve the sensitivity and specificity of computed tomography (CT) for many clinical indications. However, the adverse effects of ICM administration can include renal injury, life-threatening allergic-like reactions, and environmental contamination. Deep learning (DL) models can generate full-dose ICM CT images from non-contrast or low-dose ICM administration or generate non-contrast CT from full-dose ICM CT. Eliminating the need for both contrast-enhanced and non-enhanced imaging or reducing the amount of required contrast while maintaining diagnostic capability may reduce overall patient risk, improve efficiency and minimize costs. We reviewed the current capabilities of DL to reduce the need for contrast administration in CT.

METHODS

We conducted a systematic review of articles utilizing DL to reduce the amount of ICM required in CT, searching MEDLINE, Embase, Compendex, Inspec, and Scopus to identify papers published from 2016 to 2022. We classified the articles based on the DL model and ICM reduction.

RESULTS

Eighteen papers met the inclusion criteria for analysis. Of these, ten generated synthetic full-dose (100%) ICM from real non-contrast CT, while four augmented low-dose to full-dose ICM CT. Three used DL to create synthetic non-contrast CT from real 100% ICM CT, while one paper used DL to translate the 100% ICM to non-contrast CT and vice versa. DL models commonly used generative adversarial networks trained and tested by paired contrast-enhanced and non-contrast or low ICM CTs. Image quality metrics such as peak signal-to-noise ratio and structural similarity index were frequently used for comparing synthetic versus real CT image quality.

CONCLUSION

DL-generated contrast-enhanced or non-contrast CT may assist in diagnosis and radiation therapy planning; however, further work to optimize protocols to reduce or eliminate ICM for specific pathology is still needed along with a dedicated assessment of the clinical utility of these synthetic images.

BiRPN-YOLOvX: A weighted bidirectional recursive feature pyramid algorithm for lung nodule detection

BACKGROUND

Lung cancer has the second highest cancer mortality rate in the world today. Although lung cancer screening using CT images is a common way for early lung cancer detection, accurately detecting lung nodules remains a challenged issue in clinical practice.

OBJECTIVE

This study aims to develop a new weighted bidirectional recursive pyramid algorithm to address the problems of small size of lung nodules, large proportion of background region, and complex lung structures in lung nodule detection of CT images.

METHODS

First, the weighted bidirectional recursive feature pyramid network (BiPRN) is proposed, which can increase the ability of network model to extract feature information and achieve multi-scale fusion information. Second, a CBAM_CSPDarknet53 structure is developed to incorporate an attention mechanism as a feature extraction module, which can aggregate both spatial information and channel information of the feature map. Third, the weighted BiRPN and CBAM_CSPDarknet53 are applied to the YOLOvX model for lung nodule detection experiments, named BiRPN-YOLOvX, where YOLOvX represents different versions of YOLO. To verify the effectiveness of our weighted BiRPN and CBAM_ CSPDarknet53 algorithm, they are fused with different models of YOLOv3, YOLOv4 and YOLOv5, and extensive experiments are carried out using the publicly available lung nodule datasets LUNA16 and LIDC-IDRI. The training set of LUNA16 contains 949 images, and the validation and testing sets each contain 118 images. There are 1987, 248 and 248 images in LIDC-IDRI's training, validation and testing sets, respectively.

RESULTS

The sensitivity of lung nodule detection using BiRPN-YOLOv5 reaches 98.7% on LUNA16 and 96.2% on LIDC-IDRI, respectively.

CONCLUSION

This study demonstrates that the proposed new method has potential to help improve the sensitivity of lung nodule detection in future clinical practice.